Swiss Biotech Firm, Chinese Crypto Miner Boost IPO Pipeline

Law360 (April 27, 2020, 7:38 PM EDT) — A Swiss oncology firm and a Chinese cryptocurrency miner have filed U.S. initial public offerings estimated to raise a combined $200 million, boosting the May pipeline as more companies eye public markets amid signs of a thawing IPO market.

Switzerland-based ADC Therapeutics SA and Zhejiang-based Ebang International Holdings Inc. filed IPOs on Friday preliminarily listed at $100 million each. The companies have yet to disclose how many shares they plan to sell or at what price range, which are figures that are typically released as the IPO process moves forward. Based on a typical IPO timetable, the companies could price their…

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.

  • Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
  • Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
  • Create custom alerts for specific article and case topics and so much more!


Source link

Stay in the Loop

Get the daily email from CryptoNews that makes reading the news actually enjoyable. Join our mailing list to stay in the loop to stay informed, for free.

Latest stories

- Advertisement - spot_img

You might also like...